Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Diğer Dergilerde Yayınlanan Makaleler

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2023 identifier

miRNAS leading to increase susceptibility of hereditary ovarian cancer

Joint Meeting on 4th World Congress on Human Genetics & Genetic Diseases and 3rd International Conference on Molecular Medicine & Diagnostics, Dubai, Birleşik Arap Emirlikleri, 19 - 20 Nisan 2018, cilt.12, ss.85 Sürdürülebilir Kalkınma

The high expression levels of miRNAs in BRCA1 related hereditary ovarian cancer

Joint Meeting on 4th World Congress on Human Genetics & Genetic Diseases and 3rd International Conference on Molecular Medicine & Diagnostics, Dubai, Birleşik Arap Emirlikleri, 19 - 20 Nisan 2018, cilt.12, ss.84 Sürdürülebilir Kalkınma

Frequency of rearrangements versus small indels mutations in BRCA1 and BRCA2 genes in Turkishspace patients with high risk breast and ovarian cancer

Joint Meeting on 4th World Congress on Human Genetics & Genetic Diseases and 3rd International Conference on Molecular Medicine & Diagnostics, Dubai, Birleşik Arap Emirlikleri, 19 - 20 Nisan 2018, cilt.12, ss.86 Sürdürülebilir Kalkınma

miRNAs leading to increase susceptibility of hereditary ovarian cancer

4th World Congress on Human Genetics & Genetic Diseases and 3rd International Conference on Molecular Medicine & Diagnostics, Dubai, Birleşik Arap Emirlikleri, 19 - 20 Nisan 2018, cilt.12, ss.85 Creative Commons License

FREQUENCY OF BRCA1 AND BRCA2 MUTATIONS IN PATIENTS WITH UNSELECTED TRIPLE-NEGATIVE BREAST CANCER

VI. International Congress of Molecular Medicine, İstanbul, Türkiye, 22 Mayıs - 25 Eylül 2017, ss.282 Sürdürülebilir Kalkınma

Panel Gene Testing For High Risk Early Age Breast Cancer Patients in Turkey

The 43rd ISOBM Annual Congress, Chicago, Amerika Birleşik Devletleri, 1 - 06 Eylül 2016, sa.211, ss.55 Sürdürülebilir Kalkınma

WHOLE GENOME EXPRESSION LEVELS OF miRNA IN HIV NEGATIVE KAPOSI'S SARCOMA

The 43rd ISOBM Annual Congress, Chicago, Amerika Birleşik Devletleri, 1 - 06 Eylül 2016, sa.212, ss.56 Sürdürülebilir Kalkınma

Novel miRNAs in HIV Negative Kaposi’s Sarcoma Patients

The 43rd ISOBM Annual Congress, Chicago, Amerika Birleşik Devletleri, 1 - 06 Eylül 2016, sa.210, ss.54 Sürdürülebilir Kalkınma

Clinical and pathologic characteristics of ovarian cancer patients with BRCA1 and BRCA2 mutations in Turkish population

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma identifier

Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer

JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15 Sürdürülebilir Kalkınma

Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group

JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, ss.629 Sürdürülebilir Kalkınma

Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain

JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2010, cilt.28, sa.15 Sürdürülebilir Kalkınma

Association between glutathione s-transferase P1 polymorphisms and time to tumor progression in small cell lung cancer patients

JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2010, cilt.28, sa.15 Sürdürülebilir Kalkınma

The future of breast cancer research and practice in Asia, Latin America, and the Middle East/North Africa: a qualitative horizon scanning analysis.

31st Annual San Antonio Breast Cancer Symposium, Phıladelphıa, Amerika Birleşik Devletleri, 15 Ocak 2009, cilt.69, sa.2, ss.328-329 Sürdürülebilir Kalkınma

Induction chemotherapy followed by chemoradiotherapy in patients with stage IIIA-B non-small cell lung cancer (NSCLC)

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.229 identifier

Detection of circulating breast cancer cells in relation to therapy.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23 identifier

Immunoreactivity to SOX-1,-2,-3 and ZIC2 antigens and correlation to survival in small cell lung cancer (SCLC).

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22 identifier

Oral etoposide in patients (pts) with Kaposi's sarcoma (KS)

EUROPEAN JOURNAL OF CANCER, Oxford, Birleşik Krallık, 01 Eylül 1997, cilt.33, sa.8, ss.1178

Oral etoposide in patients with small cell lung cancer

EUROPEAN JOURNAL OF CANCER, Oxford, Birleşik Krallık, 01 Eylül 1997, cilt.33, sa.8, ss.1072 Sürdürülebilir Kalkınma

Kitap & Kitap Bölümleri

Metrikler

Yayın

162

Atıf (WoS)

501

H-İndeks (WoS)

12

Atıf (Scopus)

519

H-İndeks (Scopus)

12

Proje

15

Tez Danışmanlığı

1

Açık Erişim

12
BM Sürdürülebilir Kalkınma Amaçları